ACCESS Newswire
12 Jan 2022, 20:13 GMT+10
Accomplished Financial Expert Led Company's First Acquisition
RESEARCH TRIANGLE PARK, NC / ACCESSWIRE / January 12, 2022 / Rho, a full-service contract research organization (CRO) with a proven track record of drug development success, has promoted Mark Ubert, MBA, to the position of Chief Financial Officer (CFO). As CFO, Mark will provide financial and strategic leadership to the growing organization, exemplified in the role he played in Rho's acquisition of European CRO Dokumeds. Mark brings more than 30 years of experience to the role of Chief Financial Officer. He joined Rho in March of 2020 as VP of Finance.
'Since joining Rho, Mark's contributions have been invaluable to driving the growth of the business, including the comprehensive global acquisition search process and identifying the ideal company to join Rho,' said Dr. Laura Helms Reece, CEO, Rho. 'His expertise and insight have made him a trusted advisor and valuable member of the executive team, and I look forward to the ongoing impact he will make in the New Year and beyond.'
'It's an absolute privilege to serve as Rho's CFO,' says Ubert. 'We have a great future ahead of us-for our teammates and our customers-and our business culture is second to none. I look forward to many rewarding, exciting years ahead with Rho.'
Prior to joining Rho, Mark served as CFO for privately held and private-equity-backed CROs. He established enhanced financial rigor specific to the CRO industry and led multiple acquisitions, from due diligence to financial integration. His career in the clinical research organization (CRO) industry began in 1999 at Quintiles, where, during his tenure, he headed regional finance operations in the US and Asia. Mark began his career with decade in public accounting, including working for KPMG and Ernst & Young.
Mark holds a BBA degree in accounting from Washburn University and an MBA degree, with an emphasis in Finance, from Keller Graduate School. He obtained his designation as a certified public accountant in 1983.
About Rho
Rho is a global, privately held contract research organization (CRO) headquartered in Research Triangle Park, a biotech hub in North Carolina, US. Rho provides a full range of drug development services, from program strategy through to clinical trials and marketing applications. For more than 36 years, Rho has been a trusted partner to some of the most innovative pharmaceutical, biotechnology and medical device companies as well as academic and government organizations. Dedicated to service excellence and cross-functional collaboration, Rho's therapeutic expertise, employee focus and commitment to strong site relationships change what it means to work with a CRO - accelerating time to market, maximizing ROI, and delivering consistent, smarter and more efficient programs. Experience Rho by following the company on Facebook, LinkedIn, Twitter, and Instagram.
MEDIA CONTACT:
Kelly Maicon (on behalf of Rho)
LARGEMOUTH COMMUNICATIONS
m: +1.919.741.9784
[email protected]
SOURCE: Rho
Get a daily dose of Chicago Chronicle news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Chicago Chronicle.
More InformationWASHINGTON, D.C.: A federal rule designed to make it easier for Americans to cancel subscriptions has been blocked by a U.S. appeals...
BASTROP, Texas: In a surprising turn at Elon Musk's X platform, CEO Linda Yaccarino announced she is stepping down, just months after...
NEW YORK CITY, New York: Former British prime minister Rishi Sunak will return to Goldman Sachs in an advisory role, the Wall Street...
LONDON, U.K.: Physically backed gold exchange-traded funds recorded their most significant semi-annual inflow since the first half...
AMSTERDAM, Netherlands: Some 32 percent of global semiconductor production could face climate change-related copper supply disruptions...
NEW YORK, New York - U.S. stocks rebounded Tuesday with all the major indices gaining ground. Markets in the UK, Europe and Canada...
WASHINGTON, D.C.: An elaborate impersonation scheme involving artificial intelligence targeted senior U.S. and foreign officials in...
(Photo credit: Kamil Krzaczynski-Imagn Images) As the 2025 WNBA season approaches its All-Star weekend, the Minnesota Lynx head to...
(Photo credit: Stan Szeto-Imagn Images) If you enjoy racing at NASCAR's snaking road courses, you have come to the right place over...
(Photo credit: Brad Penner-Imagn Images) New York Yankees left-hander Carlos Rodon was named to the American League All-Star team...
(Photo credit: Anne-Marie Sorvin-Imagn Images) It's been more than a month since San Diego FC needed to bounce back from a defeat....
(Photo credit: David Reginek-Imagn Images) Left-handed reliever Fraser Ellard returned to the Chicago White Sox for Friday's doubleheader...